A new generation of GLP-1 weight-loss drugs, such as Wegovy and Ozempic, have proven highly clinically effective at suppressing appetite and inducing significant weight loss. With over a quarter of UK adults classified as obese, the government is actively considering heavily rolling out these injections on the taxpayer-funded National Health Service (NHS) to improve public health and get sick people back to work. Proponents argue that funding these 'miracle jabs' is a mathematically sound investment that will drastically reduce the catastrophic long-term burden of obesity-related illnesses on hospitals. Opponents argue that these drugs are unsustainably expensive, require lifelong use to keep the weight off, and distractingly divert desperately needed funds away from critical care and structural health reforms.
Response rates from 1.2k UK voters.
Trend of support over time for each answer from 1.2k UK voters.
Loading data...
Loading chart...
Trend of how important this issue is for 1.2k UK voters.
Loading data...
Loading chart...
Unique answers from UK voters whose views went beyond the provided options.
@BF4RZ6Z2 days2D
@BDGCLTB 1mo1MO
@BDFP9H92mos2MO
@BDC6Z8F2mos2MO
@BDDTK892mos2MO
@BDD4GZM2mos2MO
@BDCTXJH2mos2MO
@BDCL3Z92mos2MO
Join in on the most popular conversations.
Based on 1.2k responses to this question.
These results come from iSideWith's ongoing political issues survey. We collect over a million responses per day, filter out duplicate and multiple submissions, and break the results down by political party, ideology, age, state, and census demographics (income, race, education, household).
iSideWith is non-partisan — we don't advocate for any party, candidate, or position. We report what the public tells us.
Writing about this issue? Use the live data and link back to the full results.
